Stay updated on TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new site revision entry was added to the history (v3.7.0), replacing the previous revision (v3.6.6). This indicates an update to the ClinicalTrials.gov interface and related functionality.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry v3.6.6 has been added to the record history, and the previous revision v3.6.5 has been removed, updating the page’s revision timeline.SummaryDifference0.1%

- Check51 days agoChange DetectedThe record history now displays a new Revision: v3.6.5 entry, indicating the study record has been updated to a newer version and replacing the previous v3.6.4 entry.SummaryDifference0.1%

- Check65 days agoChange DetectedThe record history now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a maintenance update to the page's revision history display.SummaryDifference0.1%

- Check87 days agoChange DetectedA new Revision: v3.6.3 entry was added to the study history and the previous Revision: v3.6.2 entry was removed. This reflects a platform update shown in the record history.SummaryDifference0.1%

- Check94 days agoChange DetectedNew revision entry v3.6.2 appears in the study record history, replacing the previous v3.6.0. This indicates a minor backend or documentation update to the page rather than changes to study content or participant data.SummaryDifference0.1%

Stay in the know with updates to TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.